These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 22240022
1. Differential effects of substrate-analogue inhibitors on nitric oxide synthase dimerization. Lee KS, Lee DK, Jeoung D, Lee H, Choe J, Ha KS, Won MH, Kwon YG, Kim YM. Biochem Biophys Res Commun; 2012 Feb 03; 418(1):49-55. PubMed ID: 22240022 [Abstract] [Full Text] [Related]
2. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. Zingarelli B, Southan GJ, Gilad E, O'Connor M, Salzman AL, Szabó C. Br J Pharmacol; 1997 Feb 03; 120(3):357-66. PubMed ID: 9031736 [Abstract] [Full Text] [Related]
3. Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Joly GA, Ayres M, Chelly F, Kilbourn RG. Biochem Biophys Res Commun; 1994 Feb 28; 199(1):147-54. PubMed ID: 7510104 [Abstract] [Full Text] [Related]
4. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells. Badn W, Hegardt P, Fellert MA, Darabi A, Esbjörnsson M, Smith KE, Janelidze S, Salford LG, Visse E, Siesjö P. Scand J Immunol; 2007 Mar 28; 65(3):289-97. PubMed ID: 17309784 [Abstract] [Full Text] [Related]
5. Impairment of osteoblast growth by nitric oxide synthase inhibitors: an effect independent of nitric oxide and arginine transport inhibition. Riancho JA, Zarrabeitia MT, Salas E, González-Macías J. Methods Find Exp Clin Pharmacol; 1996 Dec 28; 18(10):663-7. PubMed ID: 9121222 [Abstract] [Full Text] [Related]
6. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition. Suliburk JW, Helmer KS, Kennison SD, Mercer DW, Robinson EK. J Surg Res; 2005 Dec 28; 129(2):265-71. PubMed ID: 16026802 [Abstract] [Full Text] [Related]
7. Non-enzymatic production of nitric oxide (NO) from NO synthase inhibitors. Moroz LL, Norby SW, Cruz L, Sweedler JV, Gillette R, Clarkson RB. Biochem Biophys Res Commun; 1998 Dec 30; 253(3):571-6. PubMed ID: 9918769 [Abstract] [Full Text] [Related]
8. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity. Ghaznavi R, Kadkhodaee M. Arch Toxicol; 2007 Jun 30; 81(6):453-7. PubMed ID: 17039356 [Abstract] [Full Text] [Related]
9. Role of nitric oxide synthase isozymes in endotoxin-induced uveitis. Mandai M, Mittag TW, Kogishi J, Iwaki M, Hangai M, Yoshimura N. Invest Ophthalmol Vis Sci; 1996 Apr 30; 37(5):826-32. PubMed ID: 8603867 [Abstract] [Full Text] [Related]
10. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals. Kim CK, Rivier C. J Neuroendocrinol; 1998 May 30; 10(5):353-62. PubMed ID: 9663649 [Abstract] [Full Text] [Related]
11. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities. Cipolletta C, Jouzeau JY, Gegout-Pottie P, Presle N, Bordji K, Netter P, Terlain B. Br J Pharmacol; 1998 Aug 30; 124(8):1719-27. PubMed ID: 9756389 [Abstract] [Full Text] [Related]
12. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells. Koeberle PD, Ball AK. Exp Neurol; 1999 Aug 30; 158(2):366-81. PubMed ID: 10415143 [Abstract] [Full Text] [Related]
13. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification. Zhu Y, Nikolic D, Van Breemen RB, Silverman RB. J Am Chem Soc; 2005 Jan 26; 127(3):858-68. PubMed ID: 15656623 [Abstract] [Full Text] [Related]
14. Involvement of endogenous nitric oxide in the regulation of K+ channel activity in cultured human proximal tubule cells. Nakamura K, Habano W, Kojo T, Komagiri Y, Kubota T, Kubokawa M. J Physiol Sci; 2006 Dec 26; 56(6):407-13. PubMed ID: 17062169 [Abstract] [Full Text] [Related]
15. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats. Wei CL, Hon WM, Lee KH, Khoo HE. Liver Int; 2005 Jun 26; 25(3):647-56. PubMed ID: 15910502 [Abstract] [Full Text] [Related]
16. Role of nitric oxide produced by constitutive and inducible nitric oxide synthases in the mouse gastric fundus. Arab HA, Hassanpour H, Bozorgi A. Clin Exp Pharmacol Physiol; 2008 Sep 26; 35(9):1038-42. PubMed ID: 18505451 [Abstract] [Full Text] [Related]
17. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors. Schmidt K, Klatt P, Mayer B. Mol Pharmacol; 1993 Sep 26; 44(3):615-21. PubMed ID: 7690451 [Abstract] [Full Text] [Related]
18. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors. Bryk R, Lubeskie A, Wolff DJ. Arch Biochem Biophys; 1999 Sep 15; 369(2):243-51. PubMed ID: 10486143 [Abstract] [Full Text] [Related]
19. [Using NO-synthase inhibitors derived from L-arginine for preventing acute experimental lung edema development in mice]. Torkunov PA, Shabanov PD. Eksp Klin Farmakol; 2009 Sep 15; 72(2):44-6. PubMed ID: 19441729 [Abstract] [Full Text] [Related]
20. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Boer R, Ulrich WR, Klein T, Mirau B, Haas S, Baur I. Mol Pharmacol; 2000 Nov 15; 58(5):1026-34. PubMed ID: 11040050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]